Table of Content

1 Human Vaccines Market Introduction and Overview
1.1 Human Vaccines Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Human Vaccines Revenue and Market Share by Manufacturer
2.2 Manufacturers Human Vaccines Area Served, Product Types
2.3 Human Vaccines Market Competitive Situation and Trends
2.3.1 Human Vaccines Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Merck
3.1.1 Merck Company Profile
3.1.2 Human Vaccines Product Overview
3.1.3 Merck Human Vaccines Market Performance (2019-2024)
3.1.4 Merck Business Overview
3.2 Sinovac
3.2.1 Sinovac Company Profile
3.2.2 Human Vaccines Product Overview
3.2.3 Sinovac Human Vaccines Market Performance (2019-2024)
3.2.4 Sinovac Business Overview
3.3 Emergent Biosolutions
3.3.1 Emergent Biosolutions Company Profile
3.3.2 Human Vaccines Product Overview
3.3.3 Emergent Biosolutions Human Vaccines Market Performance (2019-2024)
3.3.4 Emergent Biosolutions Business Overview
3.4 Seqirus
3.4.1 Seqirus Company Profile
3.4.2 Human Vaccines Product Overview
3.4.3 Seqirus Human Vaccines Market Performance (2019-2024)
3.4.4 Seqirus Business Overview
3.5 Bavarian Nordic
3.5.1 Bavarian Nordic Company Profile
3.5.2 Human Vaccines Product Overview
3.5.3 Bavarian Nordic Human Vaccines Market Performance (2019-2024)
3.5.4 Bavarian Nordic Business Overview
3.6 Bharat Biotech
3.6.1 Bharat Biotech Company Profile
3.6.2 Human Vaccines Product Overview
3.6.3 Bharat Biotech Human Vaccines Market Performance (2019-2024)
3.6.4 Bharat Biotech Business Overview
3.7 GlaxoSmithKline (GSK)
3.7.1 GlaxoSmithKline (GSK) Company Profile
3.7.2 Human Vaccines Product Overview
3.7.3 GlaxoSmithKline (GSK) Human Vaccines Market Performance (2019-2024)
3.7.4 GlaxoSmithKline (GSK) Business Overview
3.8 Biological E. Limited
3.8.1 Biological E. Limited Company Profile
3.8.2 Human Vaccines Product Overview
3.8.3 Biological E. Limited Human Vaccines Market Performance (2019-2024)
3.8.4 Biological E. Limited Business Overview
3.9 Pfizer
3.9.1 Pfizer Company Profile
3.9.2 Human Vaccines Product Overview
3.9.3 Pfizer Human Vaccines Market Performance (2019-2024)
3.9.4 Pfizer Business Overview
3.10 Panacea Biotec
3.10.1 Panacea Biotec Company Profile
3.10.2 Human Vaccines Product Overview
3.10.3 Panacea Biotec Human Vaccines Market Performance (2019-2024)
3.10.4 Panacea Biotec Business Overview
3.11 Sanofi Pasteur
3.11.1 Sanofi Pasteur Company Profile
3.11.2 Human Vaccines Product Overview
3.11.3 Sanofi Pasteur Human Vaccines Market Performance (2019-2024)
3.11.4 Sanofi Pasteur Business Overview
4 Global Human Vaccines Historical and Forecast Market Analysis by Type
4.1 Global Human Vaccines Revenue and Market Share by Type
4.2 Global Human Vaccines Revenue Market Forecast by Type (2024-2030)
5 Global Human Vaccines Historical and Forecast Market Analysis by Application
5.1 Global Human Vaccines Revenue Market Share by Application (2019-2024)
5.2 Human Vaccines Revenue Market Forecast by Application (2024-2030)
6 Global Market Growth Trends Analysis
6.1 Global Human Vaccines Market Size & Forecast (2019-2030)
6.2 Human Vaccines Growth Trends Analysis by Regions
6.2.1 Human Vaccines Market Size by Regions: 2019 VS 2024 VS 2030
6.2.2 Human Vaccines Historic Revenue Market Size by Regions (2019-2024)
6.2.3 Human Vaccines Forecasted Revenue Market Size by Regions (2024-2030)
7 North America
7.1 North America Human Vaccines Revenue Market Size & Forecast (2019-2030)
7.2 North America Human Vaccines Revenue, Gross and Gross Margin (2019-2024)
7.3 North America PEST Analysis
8 Europe
8.1 Europe Human Vaccines Revenue Market Size & Forecast (2019-2030)
8.2 Europe Human Vaccines Revenue, Gross and Gross Margin (2019-2024)
8.3 Europe PEST Analysis
9 China
9.1 China Human Vaccines Revenue Market Size & Forecast (2019-2030)
9.2 China Human Vaccines Revenue, Gross and Gross Margin (2019-2024)
9.3 China PEST Analysis
10 Japan
10.1 Japan Human Vaccines Revenue Market Size & Forecast (2019-2030)
10.2 Japan Human Vaccines Revenue, Gross and Gross Margin (2019-2024)
10.3 Japan PEST Analysis
11 Korea
11.1 Korea Human Vaccines Revenue Market Size & Forecast (2019-2030)
11.2 Korea Human Vaccines Revenue, Gross and Gross Margin (2019-2024)
11.3 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Human Vaccines Revenue Market Size & Forecast (2019-2030)
12.2 Southeast Asia Human Vaccines Revenue, Gross and Gross Margin (2019-2024)
12.3 Southeast Asia PEST Analysis
13 India
13.1 India Human Vaccines Revenue Market Size & Forecast (2019-2030)
13.2 India Human Vaccines Revenue, Gross and Gross Margin (2019-2024)
13.3 India PEST Analysis
14 South America
14.1 South America Human Vaccines Revenue Market Size & Forecast (2019-2030)
14.2 South America Human Vaccines Revenue, Gross and Gross Margin (2019-2024)
14.3 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Human Vaccines Revenue Market Size & Forecast (2019-2030)
15.2 Middle East & Africa Human Vaccines Revenue, Gross and Gross Margin (2019-2024)
15.3 Middle East & Africa PEST Analysis
16 Human Vaccines Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 Human Vaccines Industrial Chain Analysis
17 Human Vaccines Industry Dynamic Analysis
17.1 Human Vaccines Market Trends Analysis
17.2 Human Vaccines Market Drivers Analysis
17.3 Human Vaccines Market Challenges Analysis
17.4 Human Vaccines Market Restraints Analysis